Synthesis and in vitro antibacterial activity of novel heterocyclic derivatives of 18-nor-equilenin

European Journal of Medicinal Chemistry

Volumn 41, Issue 7, 2006, Pages 891-895

  Karnik, A V ^a   Malviya, N J ^a   Kulkarni, A M ^a   Jadhav, B L ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

1,2,3,4 Tetrazol; 1,3,4 Triazole; Azasteroid; Heterocyclic analog of 18 nor equilenin; Heterosteroid; Oxasteroid and antibacterial activity; Thiasteroid

Indexed keywords

(2H 11 OXA 17 THIA 15 AZA CYCLOPENTA[A]PHENANTHRENE 16 YL)HYDRAZINE; 1 BROMO 10 METHYL 6H 5 OXA 7 THIA 8,9,10A TRIAZA PENTALENO[4,5 A]PHENANTHRENE; 1 BROMO 6H 5 OXA 7 THIA 8,9,10,10A TETRAAZA PENTALENO[4,5 A]PHENANTHRENE; 10 METHYL 6H 5 OXA 7 THIA 8,9,10A TRIAZA PENTALENO[4,5 A]PHENANTHRENE; 11 BROMO 6H 5 OXA 7 THIA 8,9,10A TRIAZA PENTALENO[4,5 A]PHENANTHRENE; 4 BROMO (12H 11 OXA 17 THIA 15 AZA CYCLOPENTA[A]PHENANTHRENE 16 YL)HYDRAZINE; 6H 5 OXA 7 THIA 8,9,10,10A TETRAAZA PENTALENO[4,5 A]PHENANTHRENE; 6H 5 OXA 7 THIA 8,9,10A TRIAZA PENTALENO[4,5 A]PHENANTHRENE; EQUILENIN; STEROID; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; FUSED HETEROCYCLIC RINGS;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; SYNTHESIS;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; EQUILENIN; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MOLECULAR STRUCTURE;

EID: 33745910894     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.01.018     Document Type: Article

References (22)

1. c M. Alauddin, M.M. Smith, J. Pharm. Pharmacol. 16 (1962) 569-595.
2. e C.I. Turner, R.M. Williamson, P. Turner, M.S. Sherburn, Chem. Comm. (2003) 1610-1611.
3. Fieser L.F., and Fieser M. Steroids 671 (1959) 847-895 (Reinhold Publishing Corporation, New York)
4. Clinton R.O., Manson A.J., Stonner F.W., Beyeler A.L., Potts G.O., and Arnold A. J. Am. Chem. Soc. 81 (1959) 1513-1514
5. Kierstead R.W., Faraone A., and Boris A. J. Med. Chem. 10 (1967) 177-181
6. Clinton R.O., Manson A.J., Stonner F.W., Neumann H.C., Chritiansen R.G., and Clarke R.L. J. Am. Chem. Soc. 83 (1961) 1478-1491
7. Li X., Singh S.M., Lourdusamy M., Merand Y., Veitleux R., and Labrie F. Bioorg. Med. Chem. Lett. 5 10 (1995) 1061-1064 (Chem. Abstr. 123 [1995] 112503f)
8. Gupta R., Pathak D., and Jindal D.P. Eur. J. Med. Chem. 31 3 (1996) 241-247
9. Anastasiou A., Catsoulacus P., and Epitheor K. Farmakol. Farmakokinet. Int. Ed. 6 3 (1992) 130-133 (Chem. Abstr., 119 [1993] 72911w)
10. Singh H., Jindal D.P., Yadav M.R., and Kumar M. Prog. Med. Chem. 28 (1991) 223-300
11. Burbiel J., and Bracher F. Steroids 68 (2003) 587-594
12. Rossum J.M., and Ariens E.J. Experientia 13 (1957) 161
13. Morand P., and Lyall J. Chem. Rev. 68 (1968) 85-124
14. Singh H., Parashar V.V., Mathur R.B., and Malhotra R.K. Indian Journal of Pharmacy 34 (1972) 1-8
15. Westra J.G., Speckamp W.N., Pandit U.K., and Huisman H.O. Tetrahedron Lett. 24 (1966) 2781-2784
16. Brown E.D., and Wright G.D. Chem. Rev. 105 (2005) 759-774
17. Spooner and Skye's (1972) 449-454.
18. Sridhar S.K., Saravanan M., and Ramesh A. Eur. J. Med. Chem. 36 (2001) 615-625
19. Atlas R.M. Handbook of Media for Clinical Microbiology (1995), CRC Press, Florida, USA [62]
20. M.E. Wolff, Burgers Medicinal Chemistry and Drug Discovery (A Wiley-Interscience Publications, New York, Ed. 5), vol. 1, 1995, pp. 15.
21. Sharma S.D., and Kaur S. Indian J. Chem. 23B (1984) 518-521
22. Subramanian L.M., and Mishra G.S. Synthesis (Mass.) 12 (1984) 1063